Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Estrogen Receptor Alpha Signaling in Endothelial Cells Exacerbates Arterial Stiffening Via Upregulation of ENaC in Insulin Resistant Females

NCT03837626 is registered in ClinicalTrials.gov with University of Missouri-Columbia as lead sponsor.

NCT NCT03837626
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03837626 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Estrogen Receptor Alpha Signaling in Endothelial Cells Exacerbates Arterial Stiffening Via Upregulation of ENaC in Insulin Resistant Females
Lead sponsor
University of Missouri-Columbia
Phase
Phase 2/3
Overall status
Completed
Start date
July 15, 2019
Completion date
April 30, 2025
Enrollment
137 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

insulin resistance, overweight and obesity